Li-Tzy Wu, DSc

Professor in Psychiatry and Behavioral Sciences
Professor in Medicine
Faculty Network Member of the Duke Institute for Brain Sciences
Affiliate of the Center for Child and Family Policy
Campus mail Duke Psychiatry, DUMC Box # 11, Durham, NC 27710
Phone (919) 889-9369
Email address

Education/Training: Pre- and post-doctoral training in mental health service research, psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute on the Design and Conduct of Randomized Clinical Trials.

Director: Duke Community Based Substance Use Disorder Research Program.
Research interests: COVID-19, Opioid misuse, Opioid overdose, Opioid use disorder, Opioid addiction prevention and treatment, Pain and addiction, Chronic diseases and substance use disorders, diabetes, pharmacy-based care models and services, medication treatment for opioid use disorder (MOUD), Drug overdose, Polysubstance use and disorders, cannabis, alcohol, tobacco, hallucinogens, stimulants, e-cigarette, SBIRT (substance use Screening, Brief Intervention, Referral to Treatment), EHR-based research and intervention, data science, psychometric analysis (IRT), epidemiology of addictions and comorbidity, behavioral health care integration, health services research (mental health disorders, substance use disorders, chronic diseases), nosology, research design, HIV risk behavior. 

FUNDED Research projects (Principal Investigator [PI], Site PI, or Sub-award PI): 
R03: Substance use/dependence (PI).
R21: Treatment use for alcohol use disorders (PI).
R21: Inhalant use & disorders (PI).
R01: MDMA/hallucinogen use/disorders (PI).
R01: Prescription pain reliever (opioids) misuse and use disorders (PI).
R01: Substance use disorders in adolescents (PI).
R21: CTN Substance use diagnoses & treatment (PI).
R33: CTN Substance use diagnoses & treatment (PI).
R01: Evolution of Psychopathology in the Population (ECA Duke site PI).
R01: Substance use disorders and treatment use among Asian Americans and Pacific Islanders (PI).
UG1: SBIRT in Primary Care (NIDA, PI).
UG1: TAPS Tool, Substance use screening tool validation in primary care (NIDA, PI).
UG1: NIDA CTN Mid-Southern Node (Clinical Trials Network, PI).
UG1: EHR Data Element Study (NIDA, PI).
UG1: Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder (NIDA, PI).
PCORI: INSPIRE-Integrated Health Services to Reduce Opioid Use While Managing Chronic Pain (Site PI).
CDC R01: Evaluation of state-mandated acute and post-surgical pain-specific CDC opioid prescribing (Site PI).
Pilot: Measuring Opioid Use Disorders in Secondary Electronic Health Records Data (Carolinas Collaborative Grant: Duke PI).
R21: Developing a prevention model of alcohol use disorder for Pacific Islander young adults (Subaward PI, Investigator).
UG1: Subthreshold Opioid Use Disorder Prevention Trial (NIH HEAL Initiative) (NIDA supplement, CTN-0101, Investigator).
NIDA: A Pilot Study to Permit Opioid Treatment Program Physicians to Prescribe Methadone through Community Pharmacies for their Stable Methadone Patients (NIDA/FRI: Study PI).
UG1: Integrating pharmacy-based prevention and treatment of opioid and other substance use disorders: A survey of pharmacists and stakeholder (NIH HEAL Initiative, NIDA, PI).
UG1: NorthStar Node of the Clinical Trials Network (NIDA, Site PI).
R34: Intervention Development and Pilot Study to Reduce Untreated Native Hawaiian and Pacific Islander Opioid Use Disorders (Subaward PI, Investigator).
UG1: Optimal Policies to Improve Methadone Maintenance Adherence Longterm (OPTIMMAL Study) (NIDA, Site PI).

Education and Training

  • D.Sc., Johns Hopkins University, 1997
  • M.A., State University of New York, New Paltz, 1992


Schranz, Asher J., Aaron Fleischauer, Vivian H. Chu, Li-Tzy Wu, and David L. Rosen. “Trends in Drug Use-Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017: A Study of Statewide Discharge Data.” Ann Intern Med 170, no. 1 (January 1, 2019): 31–40.

Full Text

John, William S., He Zhu, Paolo Mannelli, Geetha A. Subramaniam, Robert P. Schwartz, Jennifer McNeely, and Li-Tzy Wu. “Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.” Drug Alcohol Depend 194 (January 1, 2019): 468–75.

Full Text

John, William S., and Li-Tzy Wu. “Sex differences in the prevalence and correlates of emergency department utilization among adults with prescription opioid use disorder.” Subst Use Misuse 54, no. 7 (2019): 1178–90.

Full Text

Muzyk, Andrew, Zachary P. W. Smothers, Kathryn Collins, Mark MacEachern, and Li-Tzy Wu. “Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.” Subst Abus 40, no. 4 (2019): 476–83.

Full Text

Wu, Li-Tzy, He Zhu, and Udi E. Ghitza. “Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: Results from electronic health records data.” Drug Alcohol Depend 192 (November 1, 2018): 316–23.

Full Text

Mannelli, Paolo, Marvin Swartz, and Li-Tzy Wu. “Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone.” Am J Addict 27, no. 6 (September 2018): 471–76.

Full Text

Zhu, He, and Li-Tzy Wu. “National trends and characteristics of inpatient detoxification for drug use disorders in the United States.” Bmc Public Health 18, no. 1 (August 29, 2018): 1073.

Full Text

John, William S., He Zhu, Paolo Mannelli, Robert P. Schwartz, Geetha A. Subramaniam, and Li-Tzy Wu. “Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients.” Drug Alcohol Depend 187 (June 1, 2018): 79–87.

Full Text